Sponsor or institution

Clinical trials and research at Enyx Therapeutics, LLC

• 4NIH research projects

NIH-funded research (4)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Gene therapy for osteoporosis linked to ALDH2 deficiency in postmenopausal East Asian women

  A gene therapy approach is being developed to reduce osteoporosis risk in postmenopausal East Asian women who have ALDH2 deficiency and drink alcohol.

  NIH research Enyx Therapeutics, LLC · New York, United States · NIH-11402253

• One-time gene therapy to prevent alcohol-related bone loss in ALDH2-deficient postmenopausal East Asian women

  A single IV gene therapy aims to restore the ALDH2 enzyme to lower toxic acetaldehyde and help prevent alcohol-related bone loss in postmenopausal East Asian women with ALDH2 mutations.

  NIH research Enyx Therapeutics, LLC · New York, United States · NIH-11256090

• Improving the survival of transplanted fat using gene therapy

  This study is testing a new way to help fat grafts last longer in surgeries by using a special treatment that encourages blood vessel growth, which could lead to better results for patients getting these types of procedures.

  NIH research Enyx Therapeutics, LLC · New York, United States · NIH-10912162

• Gene therapy to treat hereditary angioedema

  This study is testing a new gene therapy that could help people with hereditary angioedema by using a modified virus to deliver a gene that makes a missing protein, aiming to reduce swelling attacks and keep you feeling better for a longer time.

  NIH research Enyx Therapeutics, LLC · New York, United States · NIH-10818251

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →